Daniel Hunt

General Counsel, Secretary, Vice President Corporate Development

Daniel Hunt has 20 years of legal, IP, business development, transactional, alliance management, finance, and operational experience with prominent life science companies, including Genentech, Abgenix, Roche and Chiron.

During his career he has acquired extensive experience integrating science, business legal disciplines in connection with life science transactions. Mr Hunt has led and closed hundreds of transactions with cumulative valuations in excess of $1B. Prior to joining CoMentis, Inc., Mr. Hunt was Associate General Counsel, Licensing, Contracts Management and Patent Law at Genentech, where he was responsible for managing Genentech’s business development and transactional activities in collaboration with Genentech’s business development, finance, research and alliance management groups, and was responsible for managing alliances for approved products and managing $2.5B in annual revenues from those alliances. Prior to Genentech, Mr. Hunt was the Director of Legal Affairs at Abgenix, where he was responsible for all company transactions, ranging from acquisitions and strategic collaborations to ordinary course transactions, and engaged in strategic planning for business development, product development, acquisition and manufacturing activities. At Roche Molecular Systems, Mr. Hunt was Chief Corporate Counsel. He was responsible for business development and transactional support and managed Roche’s PCR licensing program. Prior to Roche, Mr. Hunt was Senior Corporate Counsel at Chiron.

Mr. Hunt began his career as a patent litigator and securities attorney at the law firm of Morrison & Foerster. Mr. Hunt obtained his law degree from the University of California at Berkeley, and his B.A. in Molecular Biology from the University of Colorado, Boulder.